ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,460 | -17.7% | 5,986 | -6.7% | 0.04% | -39.7% |
| Q2 2023 | $197,289 | -5.3% | 6,418 | +11.0% | 0.06% | -13.4% |
| Q1 2023 | $208,325 | +131.5% | 5,782 | +157.8% | 0.07% | +52.3% |
| Q3 2022 | $90,000 | -6.2% | 2,243 | -1.3% | 0.04% | -25.4% |
| Q2 2022 | $96,000 | +7.9% | 2,273 | +1.3% | 0.06% | +43.9% |
| Q4 2021 | $89,000 | +41.3% | 2,243 | +29.6% | 0.04% | +2.5% |
| Q3 2021 | $63,000 | – | 1,731 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |